TEACHERS ADVISORS, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2019$2,610,000
-12.2%
64,998
+0.6%
0.00%
-25.0%
Q4 2018$2,971,000
-46.4%
64,597
-48.3%
0.00%
+33.3%
Q3 2018$5,544,000
+206.0%
124,954
+170.2%
0.00%
+50.0%
Q2 2018$1,812,000
-31.3%
46,240
+26.8%
0.00%
-33.3%
Q1 2018$2,638,000
-73.0%
36,471
-75.4%
0.00%
-76.9%
Q4 2017$9,771,000
+36.4%
148,407
+3.8%
0.01%
+30.0%
Q3 2017$7,166,000
+8.7%
142,981
+0.3%
0.01%
+11.1%
Q2 2017$6,594,000
+531.6%
142,483
+382.0%
0.01%
+350.0%
Q1 2017$1,044,000
+149.2%
29,563
-11.8%
0.00%
+100.0%
Q4 2016$419,000
+41.6%
33,502
+56.7%
0.00%
Q3 2016$296,000
+40.3%
21,3800.0%0.00%
Q2 2016$211,000
-35.9%
21,380
+10.0%
0.00%
-100.0%
Q1 2016$329,000
-24.0%
19,4380.0%0.00%0.0%
Q4 2015$433,000
-5.7%
19,4380.0%0.00%0.0%
Q3 2015$459,000
-70.6%
19,438
+1.8%
0.00%
-66.7%
Q2 2015$1,561,000
+110.4%
19,091
+138.4%
0.00%
+200.0%
Q1 2015$742,000
+206.6%
8,008
+34.0%
0.00%
Q4 2014$242,000
+65.8%
5,9770.0%0.00%
Q3 2014$146,000
+53.7%
5,9770.0%0.00%
Q2 2014$95,000
+48.4%
5,977
+40.6%
0.00%
Q1 2014$64,000
+10.3%
4,2500.0%0.00%
Q4 2013$58,000
-27.5%
4,2500.0%0.00%
Q3 2013$80,0004,2500.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2019
NameSharesValueWeighting ↓
Meditor Group Ltd 2,679,835$99,609,00022.32%
Bellevue Group AG 5,465,715$203,160,0002.81%
Rhenman & Partners Asset Management AB 455,000$16,912,0001.50%
Endurant Capital Management LP 135,901$5,051,0001.49%
Boxer Capital, LLC 975,000$36,241,0001.25%
DCF Advisers, LLC 56,500$2,100,0001.07%
Pentwater Capital Management LP 2,169,022$80,623,0001.04%
Nicholas Investment Partners, LP 235,855$8,767,0000.95%
Amia Capital LLP 20,464$761,0000.88%
HAMILTON LANE ADVISORS LLC 46,181$1,717,0000.83%
View complete list of ESPERION THERAPEUTICS INC NE shareholders